|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 209/18 | |
| C07D 409/06 | |||
| C07D 403/12 | |||
| A61K 31/404 | |||
| A61P 35/00 |
| (11) | Patento numeris | 3434668 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17769483.3 |
| Europos patento paraiškos padavimo data | 2017-03-24 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-01-30 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-08-26 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/CN2017/078139 |
| Data | 2017-03-24 |
| (87) | Numeris | WO 2017/162206 |
| Data | 2017-09-28 |
| (30) | Numeris | Data | Šalis |
| 201610180518 | 2016-03-25 | CN | |
| 201610867918 | 2016-09-29 | CN |
| (72) |
LU, Jianyu, CN
DING, Charles Z., CN
HU, Lihong, CN
HE, Huijun, CN
CHEN, Shuhui, CN
DONG, Jiaqiang, CN
WANG, Tie-Lin, CN
|
| (73) |
Luoxin Pharmaceutical (Shanghai) Co., Ltd.,
1st-3rd Floor, Building 2, Building 1 No. 85 Faladi Road, China (Shanghai) Pilot Free Trade Zone Shanghai 201210,
CN
Shandong Luoxin Pharmaceutical Group Stock Co., Ltd., Luoqi Road Linyi High and New Technology Industries Development Zone, Linyi, Shandong 276017, CN |
| (54) | INDOLO-SUBSTITUTED-PIPERIDINE COMPOUNDS AS ESTROGEN RECEPTOR DEGRADING AGENT |
| INDOLO-SUBSTITUTED-PIPERIDINE COMPOUNDS AS ESTROGEN RECEPTOR DEGRADING AGENT |